Bibliographic Details
Title: |
Small interfering RNA targeting of the survivin gene inhibits human tumor cell growth in vitro. |
Authors: |
ZHAOXIA ZHANG, TIANYOU WANG, ZIQIN LIU, SUOQIN TANG, MEI YUE, SHUNQIAO FENG, MENGZE HU, LITIAN XUAN, YANFEI CHEN |
Source: |
Experimental & Therapeutic Medicine; Jul2017, Vol. 14 Issue 1, p35-42, 8p |
Subject Terms: |
SMALL interfering RNA, TUMORS, CELL proliferation, CELL division, PROPIDIUM iodide |
Abstract: |
The present study aimed to evaluate the impact of small interfering RNA (siRNA) targeting of the survivin gene in human tumor cells and the effect of decreased survivin expression on the proliferation and apoptosis of tumor cells. Human tumor cell lines (MSA-MB-231, SGC-7901, HeLa, A549, SK-OV-3 and Raji, PC-3) were cultured in vitro and divided into three groups: survivin siRNA-treated, scrambled negative control siRNA-treated and an untreated control group. The level of survivin mRNA and protein expression was subsequently determined by reverse transcription-quantitative polymerase chain reaction and western blot analysis, respectively. Cell proliferation was also examined by an MTT assay following transfection and the apoptotic rate of cells was detected by Hoechst and Annexin V/propidium iodide staining. It was observed that relative to the control group, expression of survivin mRNA and protein in the survivin siRNA-treated group was significantly downregulated. Furthermore, siRNA targeting of survivin lead to the inhibition of tumor cell proliferation, as well as an increase in their apoptotic rate in vitro. These data suggest that survivin may be a potential tumor biomarker and a novel target for the treatment of cancer. [ABSTRACT FROM AUTHOR] |
|
Copyright of Experimental & Therapeutic Medicine is the property of Spandidos Publications UK Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Complementary Index |